For the Inventor, By the Inventor

Enter assignee name

Santa Monica, CA, United States of America

John Wayne Cancer Institute

USPTO Granted Patents = 36

CIPO Patents = 1

EPO Patents = 7

Forward Citations = 514

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Dave S B Hoon (16 out of 18 patents)

Bret Taback (8 out of 8 patents)

Samuel M Shaolian (6 out of 107 patents)

4. David Hoon (6 out of 6 patents)

5. Reiko F Irie (5 out of 9 patents)

6. Takanori Oka (4 out of 9 patents)

7. Donald L Morton (3 out of 12 patents)

8. Myles C Cabot (3 out of 4 patents)

9. Yasufumi Kaneda (2 out of 25 patents)

10. Michiel De Maat (2 out of 2 patents)

11. Bruce Seligmann (1 out of 17 patents)

12. Hui Wang (1 out of 17 patents)

13. Mepur H Ravindranath (1 out of 3 patents)

14. Krishna Maddula (1 out of 2 patents)

15. Christopher Roberts (1 out of 1 patent)

36 patents: Sort by Forward Citations

1. 10987037 - Method and apparatus for in vivo surveillance of circulating biological components (2021-04-27),

2. 9758829 - Molecular malignancy in melanocytic lesions (2017-09-12),

3. 9567640 - Utility of B-RAF DNA mutation in diagnosis and treatment of cancer (2017-02-14),

4. 9556491 - Utility of B-RAF DNA mutation in diagnosis and treatment of cancer (2017-01-31),

5. 9410206 - Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer (2016-08-09),

6. 9162884 - Method and apparatus for in vivo surveillance of circulating biological components (2015-10-20),

7. 9156898 - Treatment of cancer and compositions (2015-10-13),

8. 9074253 - Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types (2015-07-07),

9. 8569044 - Method and apparatus for in vivo collection of circulating biological components (2013-10-29),

10. 8288099 - Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer (2012-10-16),

11. 8084246 - Method and apparatus for in vivo surveillance of circulating biological components (2011-12-27),

12. 8039218 - Detection of cancer cells in body fluids (2011-10-18),

13. 7993909 - Method and apparatus for in vivo collection of circulating biological components (2011-08-09),

14. 7943319 - Utility of RET mutant in diagnosis and treatment of melanoma (2011-05-17),

15. 7910295 - Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR (2011-03-22),

The John Wayne Cancer Institute, an academic division of Providence Saint John’s Health Center, is recognized as a leader in cancer research, treatment, and education. It aims to eradicate cancer by delivering world-class patient care, conducting cutting-edge research, and providing exceptional educational programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

36 Patents

#8 in Santa Monica, CA

#2,179 in California

#9,198 in US

#18,193 in the World

Santa Monica, CA, United States of America

John Wayne Cancer Institute

Forward Citations = 514

30 inventors:

Dave S B Hoon (16 out of 18 patents)

Bret Taback (8 out of 8 patents)

Samuel M Shaolian (6 out of 107 patents)

4. David Hoon (6 out of 6 patents)

5. Reiko F Irie (5 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…